Information regarding the gross amounts of our derivative instruments in the unaudited interim Consolidated Balance Sheets is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Asset Derivatives at Fair Value | | Liability Derivatives at Fair Value | | ($ in millions) | Balance Sheet Location | | October 31, 2020 (1) | | November 2, 2019 (1) | | February 1, 2020 (1) | | Balance Sheet Location | | October 31, 2020 (1) | | November 2, 2019 (1) | | February 1, 2020 (1) | | | | | | | | | | | | | | | | | | Interest rate swaps | Prepaid expenses and other | | $ | — | | | $ | — | | | $ | — | | | Other accounts payable and accrued expenses | | $ | 77 | | | $ | — | | | $ | — | | | Interest rate swaps | Other assets | | — | | | — | | | — | | | Other liabilities | | — | | | 53 | | | 58 | | | Total derivatives | | | $ | — | | | $ | — | | | $ | — | | | | | $ | 77 | | | $ | 53 | | | $ | 58 | |
(1) Derivatives as of October 31, 2020, were not designated as hedging instruments; derivatives as of November 2, 2019, and February 1, 2020, were designated as hedging instruments
|